Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma

Vidal Essebag,Jeff S. Healey,Jacqueline Joza,Pablo B. Nery,Eli Kalfon,Tiago Luiz Luz Leiria,Atul Verma,Felix Ayala Paredes,Benoit Coutu,Glen L Sumner,G Becker,François Philippon,John W. Eikelboom,Roopinder K. Sandhu,John L. Sapp,Richard Leather,Derek Yung,Bernard Thibault,Christopher S. Simpson,Kamran Ahmad,Satish Toal,M. Stürmer,Katherine Kavanagh,Eugene Crystal,George A. Wells,Andrew D. Krahn,David H. Birnie

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma

2019

Background: Oral anticoagulant use is common among patients undergoing pacemaker or defibrillator surgery. BRUISE CONTROL (Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial...

Keywords:

Heparin
Hematoma
Warfarin
Bruise
Randomized controlled trial
Anesthesia
Medicine
Anticoagulant use
Anticoagulant
oral anticoagulant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations